Aspen Pharmacare Holdings Ltd APNHF
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Aspen Pharmacare Holdings is a South-Africa based company that manufactures and sells branded and generic pharmaceutical products in two segments: commercial pharmaceuticals and manufacturing. The segment of commercial pharmaceuticals generates the majority of the company’s total revenue by marketing a variety of medicines under regional brands and sterile focus brands. The company operates globally across emerging markets and developed markets from multiple continents, including Africa, Americas, Asia, Europe, and the Pacific area, with more than half of its total revenue generated in emerging markets.
Johannesburg, 2052, South Africa